IDEXX Laboratories (IDXX) Short Interest Ratio & Short Volume → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free IDXX Stock Alerts $503.02 -6.80 (-1.33%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability IDEXX Laboratories Short Interest DataCurrent Short Volume1,690,000 sharesPrevious Short Volume1,710,000 sharesChange Vs. Previous Month-1.17%Dollar Volume Sold Short$832.76 millionShort Interest Ratio / Days to Cover3.9Last Record DateApril 30, 2024Outstanding Shares82,587,000 sharesFloat Size81,770,000 sharesShort Percent of Float2.07%Today's Trading Volume372,963 sharesAverage Trading Volume445,109 sharesToday's Volume Vs. Average84% Short Selling IDEXX Laboratories ? Sign up to receive the latest short interest report for IDEXX Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIDXX Short Interest Over TimeIDXX Days to Cover Over TimeIDXX Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. IDEXX Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,690,000 shares $832.76 million -1.2%2.1%3.9 $492.76 4/15/20241,710,000 shares $840.11 million -2.8%2.1%4.1 $491.29 3/31/20241,760,000 shares $950.28 million -2.2%2.1%4.2 $539.93 3/15/20241,800,000 shares $953.59 million +6.5%2.2%4.3 $529.77 2/29/20241,690,000 shares $972.14 million -8.2%2.1%3.7 $575.23 2/15/20241,840,000 shares $1.05 billion -0.5%2.2%3.9 $568.83 Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,850,000 shares $952.90 million +6.3%2.3%3.8 $515.08 1/15/20241,740,000 shares $931.40 million -5.4%2.1%3.4 $535.29 12/31/20231,840,000 shares $1.02 billion -15.6%2.2%3.5 $555.05 12/15/20232,180,000 shares $1.18 billion -18.1%2.7%4.2 $541.07 11/30/20232,660,000 shares $1.24 billion -4.0%3.2%5.2 $465.82 11/15/20232,770,000 shares $1.28 billion +0.7%3.4%5.7 $460.56 10/31/20232,750,000 shares $1.10 billion No Change3.4%5.8 $399.47 10/15/20232,750,000 shares $1.17 billion +3.8%3.4%6.3 $426.18 9/30/20232,650,000 shares $1.16 billion +7.7%3.2%5.9 $437.27 9/15/20232,460,000 shares $1.11 billion -0.8%3.0%5.4 $450.69 8/31/20232,480,000 shares $1.27 billion +8.3%3.0%5.5 $511.41 8/15/20232,290,000 shares $1.17 billion -12.9%2.8%5 $509.37 7/31/20232,630,000 shares $1.46 billion +6.5%3.2%5.8 $554.73 7/15/20232,470,000 shares $1.33 billion +8.3%3.0%5.6 $536.89 6/30/20232,280,000 shares $1.15 billion +6.1%2.8%5.6 $502.23 6/15/20232,150,000 shares $1.04 billion +3.4%2.6%5.4 $481.42 5/31/20232,080,000 shares $966.72 million -5.9%2.5%5.2 $464.77 5/15/20232,210,000 shares $1.08 billion No Change2.7%5.8 $489.88 10/31/20222,390,000 shares $859.64 million +0.8%2.9%4.5 $359.68 10/15/20222,370,000 shares $769.40 million +14.5%2.9%4.5 $324.64 9/30/20222,070,000 shares $674.41 million -2.8%2.5%3.8 $325.80 9/15/20222,130,000 shares $745.16 million +10.4%2.6%3.8 $349.84 8/31/20221,930,000 shares $670.91 million -1.5%2.3%3.4 $347.62 8/15/20221,960,000 shares $766.07 million +18.1%2.4%3.3 $390.85 7/31/20221,660,000 shares $662.64 million -12.2%2.0%2.5 $399.18 7/15/20221,890,000 shares $699.56 million -4.6%2.3%2.6 $370.14 6/30/20221,980,000 shares $694.45 million +1.5%2.4%2.8 $350.73 6/15/20221,950,000 shares $651.18 million +7.7%2.3%2.8 $333.94 5/31/20221,810,000 shares $708.83 million +28.4%2.2%2.8 $391.62 5/15/20221,410,000 shares $510.67 million +13.7%1.7%2.2 $362.18 4/30/20221,240,000 shares $533.80 million +17.0%1.5%2.2 $430.48 4/15/20221,060,000 shares $526.59 million +3.9%1.3%2 $496.78 3/31/20221,020,000 shares $558.00 million +20.7%N/A1.9 $547.06 3/15/2022845,000 shares $424.98 million +7.4%1.0%1.7 $502.93Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… IDXX Short Interest - Frequently Asked Questions What is IDEXX Laboratories' current short interest? Short interest is the volume of IDEXX Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,690,000 shares of IDXX short. 2.07% of IDEXX Laboratories' shares are currently sold short. Learn More on IDEXX Laboratories' current short interest. What is a good short interest ratio for IDEXX Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDXX shares currently have a short interest ratio of 4.0. Learn More on IDEXX Laboratories's short interest ratio. Which institutional investors are shorting IDEXX Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IDEXX Laboratories: Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for IDEXX Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.07% of IDEXX Laboratories' floating shares are currently sold short. Is IDEXX Laboratories' short interest increasing or decreasing? IDEXX Laboratories saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 1,690,000 shares, a decrease of 1.2% from the previous total of 1,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IDEXX Laboratories' float size? IDEXX Laboratories currently has issued a total of 82,587,000 shares. Some of IDEXX Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IDEXX Laboratories currently has a public float of 81,770,000 shares. How does IDEXX Laboratories' short interest compare to its competitors? 2.07% of IDEXX Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IDEXX Laboratories: Alcon Inc. (0.67%), Centene Co. (1.44%), Humana Inc. (2.70%), IQVIA Holdings Inc. (1.62%), Haleon plc (0.53%), Takeda Pharmaceutical Company Limited (0.20%), GE HealthCare Technologies Inc. (2.73%), Cencora, Inc. (4.88%), Moderna, Inc. (6.26%), Biogen Inc. (2.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short IDEXX Laboratories stock? Short selling IDXX is an investing strategy that aims to generate trading profit from IDEXX Laboratories as its price is falling. IDXX shares are trading down $6.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IDEXX Laboratories? A short squeeze for IDEXX Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDXX, which in turn drives the price of the stock up even further. How often is IDEXX Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDXX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Alcon Short Interest Centene Short Interest Humana Short Interest IQVIA Short Interest Haleon Short Interest Takeda Pharmaceutical Short Interest GE HealthCare Technologies Short Interest Cencora Short Interest Moderna Short Interest Biogen Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IDXX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders